A detailed history of Royal Bank Of Canada transactions in 908 Devices Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 2,137 shares of MASS stock, worth $5,470. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,137
Previous 2,241 4.64%
Holding current value
$5,470
Previous $11,000 36.36%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.45 - $6.17 $358 - $641
-104 Reduced 4.64%
2,137 $7,000
Q2 2024

Aug 14, 2024

BUY
$5.0 - $7.24 $8,335 - $12,069
1,667 Added 290.42%
2,241 $11,000
Q1 2024

Nov 05, 2024

SELL
$6.55 - $9.92 $10,918 - $16,536
-1,667 Reduced 74.39%
574 $4,000
Q1 2024

May 15, 2024

SELL
$6.55 - $9.92 $41,540 - $62,912
-6,342 Reduced 91.7%
574 $4,000
Q4 2023

Feb 14, 2024

BUY
$4.96 - $12.41 $10,887 - $27,239
2,195 Added 46.49%
6,916 $77,000
Q3 2023

Nov 14, 2023

SELL
$6.0 - $8.2 $7,794 - $10,651
-1,299 Reduced 21.58%
4,721 $31,000
Q2 2023

Aug 14, 2023

SELL
$5.78 - $10.02 $101,687 - $176,281
-17,593 Reduced 74.51%
6,020 $41,000
Q1 2023

May 15, 2023

SELL
$6.61 - $10.66 $209,041 - $337,122
-31,625 Reduced 57.25%
23,613 $203,000
Q4 2022

Feb 14, 2023

BUY
$7.0 - $17.96 $24,311 - $62,375
3,473 Added 6.71%
55,238 $420,000
Q3 2022

Nov 14, 2022

BUY
$15.18 - $24.99 $780,479 - $1.28 Million
51,415 Added 14690.0%
51,765 $851,000
Q2 2022

Aug 15, 2022

SELL
$13.3 - $20.74 $13,632 - $21,258
-1,025 Reduced 74.55%
350 $8,000
Q1 2022

May 16, 2022

SELL
$13.18 - $26.28 $37,997 - $75,765
-2,883 Reduced 67.71%
1,375 $26,000
Q4 2021

Feb 14, 2022

BUY
$23.17 - $38.77 $67,285 - $112,588
2,904 Added 214.48%
4,258 $110,000
Q3 2021

Nov 15, 2021

BUY
$29.99 - $39.13 $25,731 - $33,573
858 Added 172.98%
1,354 $44,000
Q2 2021

Aug 16, 2021

BUY
$36.7 - $55.11 $18,203 - $27,334
496 New
496 $19,000

Others Institutions Holding MASS

About 908 Devices Inc.


  • Ticker MASS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,590,200
  • Market Cap $80.9M
  • Description
  • 908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-...
More about MASS
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.